The purpose of this study is to investigate pancreatic cancer. It collects radiological data to assess the condition's malignancy and prognosis.
The study evaluates the clinical outcomes of patients with pancreatic cancer, focusing on factors like progression-free survival and overall survival.
- Who can participate: Adults 18 years and older with suspected or diagnosed pancreatic cancer can join. Participants must be willing to sign informed consent.
- Study details: Participants will undergo radiological assessments as part of their standard care.